Company Registration No. 13600107 (England and Wales)
Medical Pharma Projects Limited
Unaudited accounts
for the period from 1 October 2024 to 7 March 2025
Medical Pharma Projects Limited
Unaudited accounts
Contents
Medical Pharma Projects Limited
Company Information
for the period from 1 October 2024 to 7 March 2025
Directors
Dr B Karbal
Ms R Karbal
Company Number
13600107 (England and Wales)
Registered Office
1 West Common Way
Harpenden
AL5 2LH
Accountants
Chris Burgess Accountancy Ltd
The Old Surgery
48 High Street
Chalgrove
Oxfordshire
OX44 7SS
Medical Pharma Projects Limited
Statement of financial position
as at 7 March 2025
Cash at bank and in hand
135,480
184,093
Creditors: amounts falling due within one year
249
(24,470)
Net current assets
139,667
179,661
Total assets less current liabilities
139,667
200,671
Creditors: amounts falling due after more than one year
-
(17,604)
Provisions for liabilities
Net assets
139,667
179,075
Called up share capital
100
100
Profit and loss account
139,567
178,975
Shareholders' funds
139,667
179,075
For the period ending 7 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2025 and were signed on its behalf by
Dr B Karbal
Director
Company Registration No. 13600107
Medical Pharma Projects Limited
Notes to the Accounts
for the period from 1 October 2024 to 7 March 2025
Medical Pharma Projects Limited is a private company, limited by shares, registered in England and Wales, registration number 13600107. The registered office is 1 West Common Way, Harpenden, AL5 2LH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% Straight Line
Motor vehicles
20% Reducing Balance
Computer equipment
25% Straight Line
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Assets held under finance leases and hire purchase contracts are capitalised and depreciated over their useful lives. The corresponding lease or hire purchase obligation is treated in the balance sheet as a liability. The interest element of rental obligations is charged to the profit and loss account over the period of the lease at a constant proportion of the outstanding balance of capital repayments.
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Medical Pharma Projects Limited
Notes to the Accounts
for the period from 1 October 2024 to 7 March 2025
4
Tangible fixed assets
Plant & machinery
Motor vehicles
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At 1 October 2024
475
35,250
5,620
41,345
Disposals
(475)
(35,250)
(6,418)
(42,143)
At 1 October 2024
357
17,202
2,776
20,335
On disposals
(357)
(17,202)
(2,776)
(20,335)
At 30 September 2024
118
18,048
2,844
21,010
Carrying values included above held under finance leases and hire purchase contracts:
£
£
Amounts falling due within one year
Accrued income and prepayments
2,155
13,830
6
Creditors: amounts falling due within one year
2025
2024
Obligations under finance leases and hire purchase contracts
-
3,602
Taxes and social security
(3,248)
19,718
7
Creditors: amounts falling due after more than one year
2025
2024
Obligations under finance leases and hire purchase contracts
-
17,604
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
Medical Pharma Projects Limited
Notes to the Accounts
for the period from 1 October 2024 to 7 March 2025
Brought
Forward
Advance/
credit
Repaid
Carried
Forward
Interest free loan, repayable upon demand
3,996
2,200
4,412
1,784
Interest free loan, repayable upon demand
2,210
-
2,210
-
10
Average number of employees
During the period the average number of employees was 2 (2024: 2).